December 11, 2012
HOLLISTON, Mass., -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that its wholly-owned subsidiary, Harvard Apparatus Regenerative Technology, Inc., filed a registration statement with the SEC for an initial public offering, or IPO, of Harvard Apparatus [...]
SCIENION’s sciFLEXARRAYER used for the production of Anagnostics’ integrated sepsis testing products
December 11, 2012
Dortmund, Germany, and St. Valentin, Austria, : SCIENION AG and Anagnostics Bioanalysis GmbH today announced that Anagnostics is using Scienion’s sciFLEXARRAYER for the production of Anagnostics new product line focusing on integrated sepsis testing, based on DNA and protein based multiplex assays. Anagnostics is specialized in developing systems and tests for multiplex diagnostics and has [...]
BioCision Raises $2.5 Million Growth Financing to Support Continued Expansion
December 11, 2012
LARKSPUR, Calif. -- BioCision LLC, a developer of sample standardization tools and solutions for the life science research and clinical markets, today announced it has raised $2.5 million in new growth financing. The round was led by BroadOak Capital Partners and included participation from Research Corporation Technologies, Inc. Comprised of debt and equity investment, funding [...]
The Big Reveal – GenTech Launches New Look
December 11, 2012
Arcade, NY, -- A new year often brings a new look, but GenTech Scientific, Inc. could not wait until New Year's to reveal its extreme website makeover, including a new logo. “The new logo has a familiar feel. It incorporates foundational design elements that preserve the company's history. Yet it also represents GenTech's vision for [...]
PerkinElmer Expands Reagent Portfolio to Accelerate Biotherapeutics Drug Development
December 11, 2012
WALTHAM, Mass. –– PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of a new range of assay kits utilizing AlphaLISA® technology to help improve the safety testing, manufacturing and quality control of biotherapeutic drugs. Biotherapeutic drug development is a rapidly growing field [...]
Personal Genome Project Canada launches
December 10, 2012
The Personal Genome Project Canada (PGP-C) launches this week giving Canadians an unprecedented opportunity to participate in a groundbreaking research study about human genetics and health. A collaborative academic research effort with Harvard Medical School's Personal Genome Project (PGP-HMS), PGP-C aims to sequence the genomes of 100 Canadians over the next year. Combined, the projects [...]
Circulomics Awarded Nearly $1M to Develop Multiplex MicroRNA Assay
December 10, 2012
BALTIMORE, MD --- Circulomics Inc has been awarded two Small Business Innovative Research (SBIR) Phase I awards, totaling $800k over 2 years, to develop its Ligo-miR microRNA assay technology and PicoSep single molecule analysis instrument. These awards were made through the National Institutes of Health's (NIH) SHIFT initiative. They foster the transformation of academic scientific [...]
CYTOO’s Motility Product Launch
December 10, 2012
Grenoble, France, – CYTOO, a life science systems & tools company providing disruptive solutions for cell-based assays and High Content Screening (HCS), will offer a significant discount on all CYTOO Motility products at the ASCB 2012 Annual meeting in San Francisco. The new product is based on CYTOO’s 2D+ Cell Culture Platform of 24 and [...]
Seegene licenses DPO™ and TOCE™ technologies to DuPont for food safety testing
December 10, 2012
Gaithersburg, Maryland and SEOUL, Korea, - Seegene Inc., (096530.KQ), a leading developer of multiplex molecular technologies and multiplex molecular diagnostic tests, today announced that it has entered into a licensing agreement with Dupont Nutrition & Health. (E.I.du Pont de Nemours and Company, NYSE:DD). This agreement marks the extension of Seegene's core molecular technologies into the [...]
Appointment of permanent CEO and Non-Executive Director
December 10, 2012
Appointment of permanent CEO The Board of Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) wishes to announce that, further to the Company’s announcement dated November 28th, 2012, Ms. Alison Mew has been appointed as the permanent Chief Executive Officer of Genetic Technologies Limited. GTG Chairman, Dr. Mal Brandon said “The Board is extremely pleased that [...]

